[HTML][HTML] Risk factors for breast cancer brain metastases: a systematic review

L Koniali, A Hadjisavvas, A Constantinidou… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Background: Brain metastasis (BM) is an increasingly common and devastating
complication of breast cancer (BC). Methods: A systematic literature search of EMBASE and …

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early …

DJ Slamon, PA Fasching, S Hurvitz… - Therapeutic …, 2023 - journals.sagepub.com
Background: Ribociclib has demonstrated a statistically significant overall survival benefit in
pre-and postmenopausal patients with hormone receptor positive/human epidermal growth …

[HTML][HTML] Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: a systematic review and meta …

EM Salvo, AO Ramirez, J Cueto, EH Law, A Situ… - The Breast, 2021 - Elsevier
Background A systematic review and meta-analysis was conducted to assess breast cancer
(BC) outcomes among patients with early-stage hormone receptor positive (HR+), human …

Analyzing breast cancer invasive disease event classification through explainable artificial intelligence

R Massafra, A Fanizzi, N Amoroso, S Bove… - Frontiers in …, 2023 - frontiersin.org
Introduction Recently, accurate machine learning and deep learning approaches have been
dedicated to the investigation of breast cancer invasive disease events (IDEs), such as …

A clinical decision support system for predicting invasive breast cancer recurrence: Preliminary results

R Massafra, A Latorre, A Fanizzi, R Bellotti… - Frontiers in …, 2021 - frontiersin.org
The mortality associated to breast cancer is in many cases related to metastasization and
recurrence. Personalized treatment strategies are critical for the outcomes improvement of …

[HTML][HTML] Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response

M Hashemi, MDA Paskeh, S Orouei, P Abbasi… - Biomedicine & …, 2023 - Elsevier
As a devastating disease, breast cancer has been responsible for decrease in life
expectancy of females and its morbidity and mortality are high. Breast cancer is the most …

Mortality after late breast cancer recurrence in Denmark

RN Pedersen, L Mellemkjær, B Ejlertsen… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Late breast cancer (BC) recurrence (ie,≥ 10 years after primary diagnosis) may
have a more favorable prognosis than earlier recurrence. We investigated the risk of BC …

Breast cancer: insights in disease and influence of drug methotrexate

V Yang, MJ Gouveia, J Santos, B Koksch… - RSC Medicinal …, 2020 - pubs.rsc.org
According to the World Health Organization, cancer is one of the leading causes of morbidity
and mortality worldwide. The previously estimated 14 million new cases in the year of 2012 …

Discordance and conversion rates of progesterone-, estrogen-, and HER2/neu-receptor status in primary breast cancer and brain metastasis mainly triggered by …

M Timmer, JM Werner, G Roehn, M Ortmann… - Anticancer …, 2017 - ar.iiarjournals.org
Background/Aim: Knowing the molecular footprint of tumors is a precondition for
personalized medicine. For breast cancer, targeted therapies are frequently based on the …

Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation

MB Moravek, R Confino, AK Lawson, KN Smith… - Breast Cancer Research …, 2021 - Springer
Purpose Breast cancer is the most common cancer in reproductive age women, and
treatment can affect fertility; however, there is often concern regarding the safety of …